Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-035364

President and CEO sold 14,000 shares at an average $35.65 ($499,096)

  • President and CEO acquired 14,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Mack David Henry · President and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-20 Exercise or conversion : show line 1 in the form +7,793 $0.53 $4,130 10,263 D
2021-05-20 Sale : show line 2 in the form −7,793 $35.60 $277,455 2,470 D
2021-05-21 Exercise or conversion : show line 3 in the form +6,207 $0.53 $3,290 8,677 D
2021-05-21 Sale : show line 4 in the form −6,207 $35.71 $221,641 2,470 D
Open-market sales · 14,000 sh · avg $35.65 · $499,096

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-05-20 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −7,793 492,867 D
2021-05-21 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −6,207 485,074 D
Loading xslF345X03/doc4.xml…